Telophase-stage host ooplasts support complete reprogramming of roscovitine-treated somatic cell nuclei in cattle.
Nuclear-cytoplasmic incompatibilities are known to play a significant role in the developmental outcome of embryos produced by nuclear transfer, particularly when metaphase arrested oocytes are used as hosts for interphase donor nuclei. To further our understanding of how cell cycle coordination affects somatic cell cloning, somatic cells at different stages of the cell cycle were fused to host oocytes either before (metaphase II, M-II) or after (telophase II, T-II) activation. To obtain cells at different stages of the cell cycle, fetal fibroblast (FF) and granulosa cells (GC) were treated with roscovitine, an inhibitor of cyclin-dependent kinases (CDKs) resulting in a large percentage of cells in S/G(2)-phase. In contrast to the M-II group, which did better with confluent cells, embryos reconstructed with T-II cytoplasts resulted in higher rates of blastocyst formation when fused to cells recovered at 16-24 h after passage. Embryos reconstructed with FF treated with roscovitine and T-II cytoplasts (Rosc/T-II) resulted in similar blastocyst rate compared to those produced with confluent cells and M-II cytoplasts (Conf/M-II). Transfer of blastocysts to surrogate heifers resulted pregnancies and birth of healthy calves from Rosc/T-II and Conf/M-II reconstructed embryos. These results indicate that, when combined with nuclear donor cells at specific cell cycle stages, M-II and T-II bovine oocytes are similarly effective in supporting the reprogramming of somatic cell nuclei.
Bordignon
V
V
Center for Research in Animal Reproduction (CRRA), Faculty of Veterinary Medicine, University of Montréal, Saint-Hyacinthe, Québec, Canada.
Smith
L C
LC
D000818:Animals; D002417:Cattle; D002453:Cell Cycle / Q000187:drug effects; D002467:Cell Nucleus / Q000378:metabolism; D065150:Cellular Reprogramming; D019976:Cloning, Organism; D004247:DNA / Q000378:metabolism; D004624:Embryo Transfer; D047108:Embryonic Development; D005260:Female; D005347:Fibroblasts; D008297:Male; D053652:Nuclear Transfer Techniques; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D011687:Purines / Q000494:pharmacology; D000077546:Roscovitine; D013692:Telophase
D047428:Protein Kinase Inhibitors; D011687:Purines; D000077546:Roscovitine; D004247:DNA